ARTICLE | Company News

Aethlon Medical, U.S. Department of Health and Human Services infectious news

September 27, 2010 7:00 AM UTC

Aethlon said it has "reestablished" efforts to develop its Hemopurifier in the U.S. Aethlon plans to conduct a pilot study of the extracorporeal device that selectively absorbs viruses and immunosuppressive toxins from the bloodstream to improve response to standard of care (SOC) in HCV patients. ...